Hyalex Orthopaedics receives FDA Breakthrough Device Designation for novel HYALEX(R) Cartilage System

LEXINGTON, Mass., July 7, 2021 -- (Healthcare Sales & Marketing Network) -- Hyalex Orthopaedics, Inc., announced that the HYALEX® Cartilage System has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). The H... Devices, Orthopaedic, FDA Hyalex Orthopaedics, HYALEX Cartilage
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news